See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Marie-Claude Pelland-Marcotte

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	40127684	0	Larouche A, Dollo V, Mercier G, et al. Impact of Obesity and Overweight on Heparin Dosing and Clinical Outcomes in Pediatric Patients with Venous Thromboembolism. Thromb Haemost. 2025 Mar 24. doi: 10.1055/a-2544-6183.
	39694444	0	Pelland-Marcotte MC, Belaktib A, Droit A, et al. Molecular signatures associated with venous thromboembolism in children with acute lymphoblastic leukemia. J Thromb Haemost. 2024 Dec 16:S1538-7836(24)00727-X. doi: 10.1016/j.jtha.2024.12.007.
	38170575	0	Sultan N, Pelland-Marcotte MC, Remy M, et al. Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies. Leuk Lymphoma. 2024 Apr;65(4):538-540. doi: 10.1080/10428194.2023.2300719. Epub 2024 Jan 3.
	38164978	0	Pelland-Marcotte MC, Kulkarni K, Tran TH, et al. Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2024 Jan 2. doi: 10.1002/ajh.27171.
	37594628	0	Pelland-Marcotte MC, Stavrakoukas A, Wong G, et al. French Canadian cross-cultural adaptation of CAPTSure(c), an index for the Clinical Assessment of Post-Thrombotic Syndrome in children. J Patient Rep Outcomes. 2023 Aug 18;7(1):83. doi: 10.1186/s41687-023-00622-7.
	37287631	0	El Maamari J, Amid A, Pelland-Marcotte MC, et al. Between Scylla and Charybdis: thrombosis in children with hemophilia. Front Pediatr. 2023 May 23;11:1173549. doi: 10.3389/fped.2023.1173549. eCollection 2023.
	36958517	0	Pelland-Marcotte MC, Bouchard V, Begin E, et al. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023 Mar 21:S1538-7836(23)00242-8. doi: 10.1016/j.jtha.2023.03.012.
	36427068	0	Pelland-Marcotte MC, Tole S, Bouhelier E, et al. Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature. Pediatr Hematol Oncol. 2022 Nov 25:1-8. doi: 10.1080/08880018.2022.2150797.
	36326142	0	Zabeida A, Winikoff R, Pelland-Marcotte MC, et al. COVID-19-associated coagulopathy in children: A multicenter observational cohort study. Pediatr Blood Cancer. 2022 Nov 3:e30079. doi: 10.1002/pbc.30079.
	33848369	0	Pelland-Marcotte MC, Kulkarni K, Athale UH, et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2021 Jul 1;96(7):796-804. doi: 10.1002/ajh.26193. Epub 2021 May 10.
	33231123	0	Lemieux-Sarrasin D, Pelland-Marcotte MC, Simonyan D, et al. Distance to the pediatric oncology center does not affect survival in children with acute lymphoblastic leukemia: a report from CYP-C. Leuk Lymphoma. 2021 Apr;62(4):960-966. doi: 10.1080/10428194.2020.1849673. Epub 2020 Nov 24.
	32557627	0	Pelland-Marcotte MC, Amiri N, Avila ML, et al. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev. 2020 Jun 18;6:CD005982. doi: 10.1002/14651858.CD005982.pub3.
	31600808	0	Pelland-Marcotte MC, Tole S, Pechlivanoglou P, et al. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis. Thromb Haemost. 2019 Dec;119(12):2034-2042. doi: 10.1055/s-0039-1697027. Epub 2019 Oct 10.
	31030810	0	Pelland-Marcotte MC, Carcao MD. Hemophilia in a Changing Treatment Landscape. Hematol Oncol Clin North Am. 2019 Jun;33(3):409-423. doi: 10.1016/j.hoc.2019.01.007. Epub 2019 Mar 29.
	30772417	0	Pelland-Marcotte MC, Tucker C, Klaassen A, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019 Mar;6(3):e144-e153. doi: 10.1016/S2352-3026(18)30224-2. Epub 2019 Feb 13.
	30141279	0	Pelland-Marcotte MC, Humpl T, James PD, et al. Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children. Br J Haematol. 2018 Oct;183(2):267-275. doi: 10.1111/bjh.15530. Epub 2018 Aug 23.